Increased rate of lung function decline in Australian adolescents with cystic fibrosis

Pediatric Pulmonology

Volumn 49, Issue 9, 2014, Pages 873-877

  Welsh, Liam ^a,b   Robertson, Colin F ^a,b   Ranganathan, Sarath C ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

cystic fibrosis; decline; lung function; Pseudomonas aeruginosa

Indexed keywords

ADOLESCENT; ARTICLE; BODY MASS; CHILD; CYSTIC FIBROSIS; DIABETES MELLITUS; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NEWBORN SCREENING; PANCREAS INSUFFICIENCY; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; SPIROMETRY; AUSTRALIA; COHORT ANALYSIS; HOSPITALIZATION; LONGITUDINAL STUDY; PANCREAS EXOCRINE INSUFFICIENCY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; AUSTRALIA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CYSTIC FIBROSIS; DIABETES MELLITUS; EXOCRINE PANCREATIC INSUFFICIENCY; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HOSPITALIZATION; HUMANS; LONGITUDINAL STUDIES; MALE; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; SPIROMETRY; YOUNG ADULT;

EID: 84906312825     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.22946     Document Type: Article

References (21)

1. United States Cystic Fibrosis Foundation. Patient registry report; 2010.
2. Konstan MW, Morgan WJ, Butler SM, Pasta DJ, Craib ML, Silva SJ, Stokes DC, Wohl ME, Wagener JS, Regelmann WE, Johnson CA,. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. J Pediatr 2007; 151: 134-139, 139e131.
3. Sanders DB, Bittner RC, Rosenfeld M, Hoffman LR, Redding GJ, Goss CH,. Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation. Am J Respir Crit Care Med 2010; 182: 627-632.
4. Sanders DB, Bittner RC, Rosenfeld M, Redding GJ, Goss CH,. Pulmonary exacerbations are associated with subsequent fev1 decline in both adults and children with cystic fibrosis. Pediatr Pulmonol 2011; 46: 393-400.
5. Schaedel C, de Monestrol I, Hjelte L, Johannesson M, Kornfalt R, Lindblad A, Strandvik B, Wahlgren L, Holmberg L,. Predictors of deterioration of lung function in cystic fibrosis. Pediatr Pulmonol 2002; 33: 483-491.
6. Schluchter MD, Konstan MW, Davis PB,. Jointly modelling the relationship between survival and pulmonary function in cystic fibrosis patients. Stat Med 2002; 21: 1271-1287.
7. Waters V, Stanojevic S, Atenafu EG, Lu A, Yau Y, Tullis E, Ratjen F,. Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis. Eur Respir J 2012; 40: 61-66.
8. Massie RJ, Curnow L, Glazner J, Armstrong DS, Francis I,. Lessons learned from 20 years of newborn screening for cystic fibrosis. Med J Aust 2012; 196: 67-70.
9. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver B, Enright PL, Hankinson JL, Ip MS, Zheng J, Stocks J,. Multi-ethnic reference values for spirometry for the 3-95 year age range: the global lung function 2012 equations. Eur Respir J 2012; 40(6): 1324-1343.
10. Cole TJ, Freeman JV, Preece MA,. British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood. Stat Med 1998; 17: 407-429.
11. Liou TG, Elkin EP, Pasta DJ, Jacobs JR, Konstan MW, Morgan WJ, Wagener JS,. Year-to-year changes in lung function in individuals with cystic fibrosis. J Cyst Fibros 2010; 9: 250-256.
12. Bell SC, Bye PT, Cooper PJ, Martin AJ, McKay KO, Robinson PJ, Ryan GF, Sims GC,. Cystic fibrosis in australia, 2009: results from a data registry. Med J Aust 2011; 195: 396-400.
13. Hoo AF, Thia LP, Nguyen TT, Bush A, Chudleigh J, Lum S, Ahmed D, Lynn IB, Carr SB, Chavasse RJ, Costeloe KL, Price J, Shankar A, Wallis C, Wyatt HA, Wade A, Stocks J,. Lung function is abnormal in 3-month-old infants with cystic fibrosis diagnosed by newborn screening. Thorax 2012; 67: 874-881.
14. Stick SM, Brennan S, Murray C, Douglas T, von Ungern-Sternberg BS, Garratt LW, Gangell CL, De Klerk N, Linnane B, Ranganathan S, Robinson P, Robertson C, Sly PD,. Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr 2009; 155: 623-628, e621.
15. Mott LS, Park J, Murray CP, Gangell CL, de Klerk NH, Robinson PJ, Robertson CF, Ranganathan SC, Sly PD, Stick SM,. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax 2012; 67: 509-516.
16. Brody AS, Klein JS, Molina PL, Quan J, Bean JA, Wilmott RW,. High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests. J Pediatr 2004; 145: 32-38.
17. de Jong PA, Lindblad A, Rubin L, Hop WC, de Jongste JC, Brink M, Tiddens HA,. Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis. Thorax 2006; 61: 80-85.
18. de Jong PA, Nakano Y, Lequin MH, Mayo JR, Woods R, Pare PD, Tiddens HA,. Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis. Eur Respir J 2004; 23: 93-97.
19. Gustafsson PM, De Jong PA, Tiddens HA, Lindblad A,. Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis. Thorax 2008; 63: 129-134.
20. Schechter MS, McColley SA, Silva S, Haselkorn T, Konstan MW, Wagener JS,. Association of socioeconomic status with the use of chronic therapies and healthcare utilization in children with cystic fibrosis. J Pediatr 2009; 155: 634-639, e631-e634.
21. Schechter MS, Shelton BJ, Margolis PA, Fitzsimmons SC,. The association of socioeconomic status with outcomes in cystic fibrosis patients in the united states. Am J Respir Crit Care Med 2001; 163: 1331-1337.